Cargando…
Incidence and risk factors of acute kidney injury in cancer patients treated with immune checkpoint inhibitors: a systematic review and meta-analysis
BACKGROUND: The incidence and risk factors of acute kidney injury (AKI) in patients with malignancies receiving immune checkpoint inhibitors (ICIs) are being extensively reported with their widespread application. OBJECTIVE: This study aimed to quantify the incidence and identify risk factors of AKI...
Autores principales: | Liu, Caihong, Wei, Wei, Yang, Letian, Li, Jian, Yi, Cheng, Pu, Yajun, Yin, Ting, Na, Feifei, Zhang, Ling, Fu, Ping, Zhao, Yuliang |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10258324/ https://www.ncbi.nlm.nih.gov/pubmed/37313406 http://dx.doi.org/10.3389/fimmu.2023.1173952 |
Ejemplares similares
-
Kidney health in the COVID-19 pandemic: An umbrella review of meta-analyses and systematic reviews
por: Yang, Letian, et al.
Publicado: (2022) -
Acute kidney injury in patients treated with immune checkpoint inhibitors
por: Gupta, Shruti, et al.
Publicado: (2021) -
On the Road to Immunotherapy—Prospects for Treating Head and Neck Cancers With Checkpoint Inhibitor Antibodies
por: Ward, Frank J., et al.
Publicado: (2018) -
TNF-α Inhibitors and Other Biologic Agents for the Treatment of Immune Checkpoint Inhibitor-Induced Myocarditis
por: Liu, Xiaohang, et al.
Publicado: (2022) -
The association between antibiotic use and outcomes of HCC patients treated with immune checkpoint inhibitors
por: Zhang, Lilong, et al.
Publicado: (2022)